Back to search
FDAFDA · Food and drugs·Recall number D-0297-2022

Betamethasone Dipropionate Lotion USP, 0.05% (Augmented), 30 mL bottle, (29 g), Rx Only, Teligent Pharma Inc., Buena, NJ, 08310, NDC 52565-023-29

Published January 5, 2022 · Recall initiated: August 23, 2021

Summary

FDA records drug Class II recall D-0297-2022, published January 5, 2022 and initiated August 23, 2021. Recalling firm: Teligent Pharma, Inc.; Status: Terminated; Reported quantity: 3,792 bottles; Lot: Lot # 16569, Exp 9/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications: lot did not meet specification for the Active Pharmaceutical Ingredient (API) particle test, which was determined through routine stability testing

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teligent Pharma, Inc.
Distributor
Distributed Nationwide in the USA
Lot
Lot # 16569, Exp 9/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Betamethasone Dipropionate Lotion USP, 0.05% (Augmented), 30 mL bottle, (29 g), Rx Only, Teligent Pharma Inc., Buena, NJ, 08310, NDC 52565-023-29 recalled?

Yes. FDA published recall D-0297-2022 on January 5, 2022. Reported hazard: Failed Stability Specifications: lot did not meet specification for the Active Pharmaceutical Ingredient (API) particle test, which was determined through routine stability testing

What should I do if I have this product?

Voluntary: Firm initiated · Letter